H.B. Fuller Company stock analysis
H.B. Fuller Company (HB1) Stock Price & Analysis
HB1 Stock Chart & Stats
- Day’s Range
- N/A
- 52-Week Range
- N/A
- Previous Close
- N/A
- Volume
- N/A
- Average Volume (3M)
- N/A
- Market Cap
- CHF 2.20B
- Enterprise Value
- CHF 5.05B
- Total Cash (Recent Filing)
- CHF 97.23M
- Total Debt (Recent Filing)
- CHF 2.05B
- Price to Earnings (P/E)
- 14.1
- Beta
- 0.67
- Next Earnings
- Jan 20, 2027 (Est.)
- EPS Estimate
- 1.12
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 1.91%
Bulls Say, Bears Say
Bulls Say
Margin Expansion
Pricing execution and restructuring savings are currently offsetting lower volume and elevated raw-material costs. Expanding gross profit and EBITDA margins can strengthen earnings durability, improve resilience across cycles, and provide funding for ongoing operational investment.
Operational Efficiency
The multi-year Quantum Leap program offers a structural path to lower conversion costs, better working-capital efficiency, and reduced maintenance capital needs. Its facility consolidation and targeted savings could support sustained margin improvement beyond temporary pricing benefits.
Medical Growth Optionality
The proposed AMS acquisition would add exposure to surgical tissue bonding, a higher-growth medical market that can diversify H.B. Fuller’s industrial and construction exposure. A larger medical platform may improve portfolio quality and balance cyclicality over time.
Bears Say
Weak Cash Conversion
Reported profitability is not converting efficiently into cash, limiting the funds available for debt reduction, acquisitions, and internal investment. Persistently weak conversion would leave the company more dependent on financing and less able to absorb demand or cost pressure.
Leverage And Financing Burden
H.B. Fuller already carries meaningful debt, while acquisition financing adds fixed interest obligations before the benefits of AMS are fully realized. Management’s stated deleveraging plan is constructive, but execution remains important because leverage can constrain flexibility.
Volume And Demand Volatility
Pricing has supported reported growth, but declining volumes and uneven customer orders indicate underlying demand remains fragile in several end markets. Persistent weakness could limit revenue compounding, reduce operating leverage, and make margin gains more dependent on pricing.
HB1 FAQ
What is H.B. Fuller Company’s market cap?
When is H.B. Fuller Company’s upcoming earnings report date?
How were H.B. Fuller Company’s earnings last quarter?
Is H.B. Fuller Company overvalued?
Does H.B. Fuller Company pay dividends?
What is H.B. Fuller Company’s EPS estimate?
How many shares outstanding does H.B. Fuller Company have?
What happened to H.B. Fuller Company’s price movement after its last earnings report?
Which hedge fund is a major shareholder of H.B. Fuller Company?
What is the TipRanks Smart Score and how is it calculated?
H.B. Fuller Company Stock Smart Score
Company Description
H.B. Fuller Company
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Building Adhesive Solutions. The Hygiene, Health and Consumable Adhesives segment produces and supplies specialty industrial adhesives, such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven and hygiene, and medical and beauty. The Engineering Adhesives segment produces and supplies high performance industrial adhesives comprising reactive, light cure, two-part liquids, polyurethane, silicone, film, and fast cure products to the durable assembly, performance wood and textile, transportation, electronics, clean energy, aerospace and defense, appliance, heavy machinery, and insulating glass markets. The Construction Adhesives segment provides products used for commercial roofing, heating, ventilation, and air conditioning and insulation applications, as well as caulks and sealants for the consumer market and professional trade. The company sells its products directly to customers, as well as through distributors and retailers in North America, Latin America, Europe, India, the Middle East, Africa, and the Asia Pacific. H.B. Fuller Company was founded in 1887 and is headquartered in Saint Paul, Minnesota.
- Sector
- Basicmaterials
- Industry
- Chemicals - Specialty
- CEO
- Celeste Mastin
- Employees
- 7,100
- Website
- www.hbfuller.com
- Address
- 1200 Willow Lake Boulevard, Saint Paul, MN, 55164-0683, US
H.B. Fuller Company (HB1) Earnings & Revenues
HB1 Company Deck
HB1 Earnings Call
Earnings Call SentimentPositive
The call was predominantly positive, with strong third-quarter revenue, EBITDA, margin, EPS, cash flow, segment performance, Quantum Leap execution, and progress toward closing the AMS acquisition. The main challenges were lower volumes, volatile demand, elevated raw material costs, supply chain disruption, weakness in electronics, construction, China, and portions of HHC and BAS. Management remained confident in continued growth, margin expansion, savings realization, cash flow improvement, and deleveraging.
View all CH:HB1 earnings summaries